Literature DB >> 27328425

PTP4A3 is a target for inhibition of cell proliferatin, migration and invasion through Akt/mTOR signaling pathway in glioblastoma under the regulation of miR-137.

Liling Wang1, Jianxun Liu1, Zhiqiang Zhong1, Xuhai Gong1, Wei Liu2, Lei Shi3, Xuesong Li4.   

Abstract

Glioblastoma multiforme (GBM) is one of the most common primary malignant adult brain tumors. It is characterized by aggressive progression and poor prognosis. There is significant need to understand the mechanism of GBM malignancy and develop improved therapeutic options for GBM patients. We systematically studied the function of PTP4A3 in the malignancy of GBM. We found that PTP4A3 was upregulated in GBM tissues and cells. Knockdown of PTP4A3 expression in GBM cells inhibited cell proliferation, migration, and invasion. PTP4A3 knockdown modulated the activity of the Akt/mTOR signaling pathway by inducing de-phosphorylation of Akt and mTOR. We identified PTP4A3 as a direct target of miR-137. MiR-137 has been reported as a tumor suppressor in GBM development. In this study, overexpression of miR-137 in GBM cells also inhibited cell proliferation, migration, and invasion. Finally, restoration of PTP4A3 expression in miR-137 overexpressing cells partially reversed the inhibition of GBM cell malignancy, and the de-phosphorylation of Akt and mTOR. We identified that PTP4A3 regulated GBM via miR-137-mediated Akt/mTOR signaling pathway.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Akt; Glioblastoma multiforme; PTP4A3; mTOR; miR-137

Mesh:

Substances:

Year:  2016        PMID: 27328425     DOI: 10.1016/j.brainres.2016.06.026

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  9 in total

1.  Hypoxia-Induced miR-137 Inhibition Increased Glioblastoma Multiforme Growth and Chemoresistance Through LRP6.

Authors:  Dong-Mei Li; Qiu-Dan Chen; Gui-Ning Wei; Jie Wei; Jian-Xing Yin; Jun-Hui He; Xin Ge; Zhu-Mei Shi
Journal:  Front Oncol       Date:  2021-02-25       Impact factor: 6.244

2.  miR-330-5p suppresses glioblastoma cell proliferation and invasiveness through targeting ITGA5.

Authors:  Linsen Feng; Jianhua Ma; Haiming Ji; Yichun Liu; Weixing Hu
Journal:  Biosci Rep       Date:  2017-06-21       Impact factor: 3.840

Review 3.  Potential Epigenetic-Based Therapeutic Targets for Glioma.

Authors:  Lanlan Zang; Shukkoor Muhammed Kondengaden; Fengyuan Che; Lijuan Wang; Xueyuan Heng
Journal:  Front Mol Neurosci       Date:  2018-11-15       Impact factor: 5.639

4.  Mechanism of microRNA-431-5p-EPB41L1 interaction in glioblastoma multiforme cells.

Authors:  Xiaoyong Han; Xirui Wang; Hui Li; Hui Zhang
Journal:  Arch Med Sci       Date:  2019-09-26       Impact factor: 3.318

5.  Protein tyrosine phosphatase 4A3 (PTP4A3/PRL-3) drives migration and progression of T-cell acute lymphoblastic leukemia in vitro and in vivo.

Authors:  M Wei; M G Haney; D R Rivas; J S Blackburn
Journal:  Oncogenesis       Date:  2020-01-30       Impact factor: 7.485

6.  Olive Leaf Extract (OLE) impaired vasopressin-induced aquaporin-2 trafficking through the activation of the calcium-sensing receptor.

Authors:  Marianna Ranieri; Annarita Di Mise; Mariangela Centrone; Mariagrazia D'Agostino; Stine Julie Tingskov; Maria Venneri; Tommaso Pellegrino; Graziana Difonzo; Francesco Caponio; Rikke Norregaard; Giovanna Valenti; Grazia Tamma
Journal:  Sci Rep       Date:  2021-02-25       Impact factor: 4.379

7.  A screen of FDA-approved drugs identifies inhibitors of protein tyrosine phosphatase 4A3 (PTP4A3 or PRL-3).

Authors:  Dylan R Rivas; Mark Vincent C Dela Cerna; Caroline N Smith; Shilpa Sampathi; Blaine G Patty; Donghan Lee; Jessica S Blackburn
Journal:  Sci Rep       Date:  2021-05-13       Impact factor: 4.379

8.  Celecoxib attenuates hepatocellular proliferative capacity during hepatocarcinogenesis by modulating a PTEN/NF-κB/PRL-3 pathway.

Authors:  Cong Zhang; Junxuan Zhou; Junjie Hu; Sheng Lei; Ming Yuan; Liang Chen; Guihong Wang; Zhenpeng Qiu
Journal:  RSC Adv       Date:  2019-07-02       Impact factor: 4.036

Review 9.  Exosome-based strategies for diagnosis and therapy of glioma cancer.

Authors:  Mohsen Karami Fath; Jalil Azami; Alireza Masoudi; Reza Mosaddeghi Heris; Elnaz Rahmani; Fatemeh Alavi; Armina Alagheband Bahrami; Zahra Payandeh; Bahman Khalesi; Masoomeh Dadkhah; Navid Pourzardosht; Vahideh Tarhriz
Journal:  Cancer Cell Int       Date:  2022-08-21       Impact factor: 6.429

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.